Parameter
| Biomarker | NR3C1 | Full name | Nuclear receptor subfamily 3 croup C member 1 | Molecular Type | Nucleic acid (miRNA) |
|---|---|---|---|---|---|
| Molecular Formula | Molecular Weight | Core Functional Dimensions | Prognosis | ||
| Disease | Non-Hodgkin Lymphoma (NHL) | Disease Subtypes | / | ||
| Organ | Lymphoid tissue | Test Sample / Technology Platform | Organizations (GEO analysis, multivariate analysis) | ||
| Pathobiological Mechanisms | High expression is associated with long survival, particularly in the CHOP treatment subgroup. | ||||
| Clinical Availability Status | Research validation phase: Retrospective analysis of 952 cases supports the need for prospective validation and stability assessment of detection. | ||||
| Notes and Dynamics | Validation of the era value of R-CHOP and development of blood sample testing methods. | ||||